is a D' filler in orthotics arch support

Checking Date & Time
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web

D' filler orthotics arch support material

Finding Sources
Searching PubMed

"D filler" orthotic arch support

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
The term "D' filler" (sometimes written "D-filler" or "D prime filler") is not found in the medical textbook library or PubMed indexed literature as a standard clinical term. It appears to be a trade/brand-specific or regional orthotic lab term rather than a universally standardized clinical term.
Here is what is known from orthotic practice:

D' Filler in Foot Orthotics

In orthotic/prosthetic fabrication, a filler refers to material used to fill the void (empty space) under the arch of a custom orthotic shell — the area between the plantar surface of the arch and the flat ground contact of the insole. This is necessary because custom orthotics are contoured to the foot's arch shape, leaving a concave space underneath.

What "D' filler" likely refers to:

A D' filler (D-prime filler) is most likely a density designation for the foam or material used to fill this arch void. In orthotic materials, foams and EVA (ethylene-vinyl acetate) are graded by Shore durometer hardness and density codes (e.g., "35D", "40D", "45D" etc.). The "D" typically denotes durometer (hardness) and the prime (') or number indicates a specific density grade used by a particular lab or manufacturer.

Function of arch filler material in orthotics:

  • Fills the concave void beneath the arch contour of the shell so the orthotic lies flat and stable in the shoe
  • Transmits load from the shell to the shoe — effectively acts as an intermediary support layer
  • Controls flexibility — a firmer (higher D) filler provides more rigid arch support; a softer filler allows more dynamic flex
  • Prevents shell rocking — without filler, the arch shell would rock on its edges in the shoe

Common filler materials:

MaterialProperties
EVA foam (various densities)Lightweight, shock-absorbing, most common
PlastazoteVery soft, moldable, used in diabetic/accommodative orthotics
PoronViscoelastic, good cushioning
CorkFirm, traditional, used in dress orthotics

In summary: A "D' filler" in orthotics is most likely a density/grade designation for the foam material used to fill the arch void space in a custom orthotic device. The specific meaning of "D'" would depend on the orthotic laboratory's internal materials coding system, and the term is not standardized across all manufacturers or clinical literature.
If you can provide more context (e.g., which lab or product line uses this term, or what the full specification reads), a more precise answer can be given.
attachment
attachment

podiatry UK - what is the pathophysiology for these conditions, the risk factors, the assessment and management including conservative, second line, and last resort. Also give me a orthotic prescription and explain why you use the materials and padding, and give me the gait analysis and deviations in an affected patient.

Now I understand the context — this is the WLV Podiatry module 5AH027, and the "D' Filler" is the arch fill component on the Simple Insole Prescription Form (6mm standard EVA/foam block used to fill the medial arch void). Let me search the library in parallel for all 5 conditions.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Good — I have solid library hits. Let me read the most relevant sections in parallel for all 5 conditions.
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
I now have sufficient textbook data to construct a comprehensive answer. Let me also check hallux limitus/rigidus more specifically.
Reading File
Now I have everything needed. Let me compile the full comprehensive study guide.

5AH027 — MSK Podiatry Exam Preparation

WLV Podiatry | All 5 Conditions — Complete Reference Guide


1. PLANTAR FASCIOPATHY

Pathophysiology

Plantar fasciopathy (preferred term over "fasciitis" as it reflects a degenerative rather than primarily inflammatory process) involves repetitive tensile loading at the medial calcaneal tuberosity — the origin of the plantar fascia. Micro-tears accumulate faster than healing can occur, causing a failed tendon repair response (tendinosis-like change): collagen disorganisation, angiofibroblastic hyperplasia, and mucinous degeneration. The fascia itself thickens (normally ≤4mm; in fasciopathy >4mm on ultrasound). Histology shows collagen necrosis and fibroblast proliferation with minimal inflammatory infiltrate — hence the shift from "itis" to "opathy."
The windlass mechanism is central: dorsiflexion of the hallux tightens the plantar fascia, raises the medial longitudinal arch, and supinates the subtalar joint (Hicks, 1954). Failure of this mechanism — or its chronic overloading — perpetuates the pathology.
Risk factors:
  • Pes planus (overpronation → chronic fascial stretch) or pes cavus (rigid arch → high tensile load)
  • Equinus (gastrocnemius/soleus tightness) — ankle dorsiflexion <10° is strongly associated
  • BMI >30
  • Occupational/prolonged weight-bearing (nurses, shop workers, teachers)
  • Sudden increases in activity (e.g. couch to 5K)
  • Intrinsic muscle weakness (abductor hallucis, flexor digitorum brevis)
  • Age 40–60 years
  • Poor footwear (inadequate arch support, thin soles)

Assessment

Subjective:
  • Post-static dyskinesia — classic "first step pain" in the morning or after rest, improves with walking then worsens later
  • Medial plantar heel pain; may radiate along the arch
  • VAS/NRS pain score; impact on ADLs
Objective:
  • Palpation: maximal tenderness at medial calcaneal tuberosity (insertion of plantar fascia); distinguish from fat pad syndrome (diffuse central heel tenderness)
  • Windlass test: passive dorsiflexion of the hallux — reproduction of plantar heel pain = positive (sensitivity ~32%, specificity ~100%)
  • Silfverskiöld test: assess gastrocnemius vs combined gastrosoleus contracture (knee extended vs knee flexed ankle dorsiflexion)
  • Non-weight-bearing (NWB) and weight-bearing (WB) foot posture: Foot Posture Index (FPI-6)
  • Subtalar joint range of motion, first ray mobility
  • Muscle strength: abductor hallucis, intrinsics
  • Footwear assessment
Investigations:
  • Weight-bearing X-ray (AP, lateral, oblique): exclude stress fracture, calcaneal spur (present in ~50% but not causally diagnostic), bone cyst
  • Ultrasound: fascia >4mm = thickened; hypoechogenicity at origin confirms degenerative change; Doppler may show neovascularisation
  • MRI: if diagnosis uncertain or nerve entrapment (Baxter's neuritis) suspected
Differential diagnosis: Baxter's neuritis (medial heel but more abductor hallucis tenderness), calcaneal stress fracture (positive squeeze test), tarsal tunnel syndrome, fat pad atrophy

Management

Conservative (First Line)

  1. Stretching protocols — plantar fascia-specific stretch (toe extension, non-weight-bearing) and Achilles tendon/gastrocnemius stretching (evidence: DiGiovanni et al.); minimum 8 weeks, 3×/day
  2. Foot orthoses — prefabricated or custom (see prescription below); aim to reduce tensile load at the fascial insertion by controlling pronation and providing heel cushioning
  3. Activity modification — reduce high-impact activity; encourage swimming/cycling
  4. Footwear advice — supportive, cushioned shoes with heel cup; avoid barefoot/flat shoes
  5. Analgesia/NSAIDs — ibuprofen 400mg TDS with food (short-term only); topical diclofenac
  6. Ice therapy — 15 minutes, 3×/day post-activity
  7. Patient education and weight management

Second Line

  1. Corticosteroid injection — ultrasound-guided is preferred; short-term relief (~1 month); risk of fat pad atrophy and fascial rupture (rupture risk at 2.67 injections — Miller's Review of Orthopaedics); maximum 2–3 injections
  2. Extracorporeal shockwave therapy (ESWT) — NICE supports its use for chronic plantar fasciopathy (>3 months); radial or focused ESWT; 3–5 sessions weekly
  3. Night splints — maintain 5° dorsiflexion overnight; reduce morning pain by preventing plantar flexion contracture
  4. Walking casts / CAM boot — for refractory cases; offloads the insertion
  5. PRP injection — emerging evidence; may offer longer relief than corticosteroid

Last Resort (Surgical)

Indicated in <5% of cases after ≥12 months of failed conservative treatment:
  • Partial plantar fasciotomy (medial third release) — endoscopic or open; full release risks arch collapse and lateral column overload (Miller's)
  • Gastrocnemius recession — indicated when isolated equinus is the primary driver
  • Concomitant Baxter's nerve release — if first branch lateral plantar nerve entrapment co-exists

Orthotic Prescription — Plantar Fasciopathy

Using the WLV Simple Insole Prescription Form:
ComponentSelectionRationale
BaseEVA 2mm (bilateral)Lightweight, semi-rigid base that provides structural control without excessive bulk; accommodates padding
'D' Filler (6mm)✓ (bilateral)Fills the medial arch void; supports the medial longitudinal arch, reducing fascial tensile strain at the calcaneal insertion by controlling calcaneal eversion and arch drop
Cobra Pad✓ (bilateral)Medial heel and arch support pad; cups the medial calcaneum, reduces fascial traction directly at origin; conforms to the medial arch
PMP (Plantar Metatarsal Pad)Not required for uncomplicated casesOnly add if forefoot pain coexists
Heel Raise (4mm)✓ (bilateral)Reduces strain on the Achilles-plantar fascia complex; effective where equinus is present or contributing; reduces heel strike impact
WedgesRF Varus 3° if FPI indicates pronated footCorrects subtalar pronation; inverts calcaneum → reduces fascial stretch
Top coverPoronViscoelastic; excellent shock absorption at heel strike; reduces impact loading on the calcaneal tuberosity
D' Filler specific rationale: The D' filler (6mm EVA) is the arch fill component. In plantar fasciopathy, the medial longitudinal arch requires support to prevent arch flattening during midstance, which would elongate the plantar fascia and increase tensile load at its insertion. The 6mm standard height provides meaningful arch contact without creating a pressure point under a tender arch. EVA density provides controlled cushioning while maintaining shape under body weight.

Gait Analysis — Plantar Fasciopathy

Observation method: Visual gait analysis (VGA), pressure plate/baropodometry, treadmill video analysis.
PhaseDeviationExplanation
Heel strike (initial contact)Reduced heel strike; toe-strike or flat-foot contact on affected sidePain avoidance strategy; patient unloads calcaneal tuberosity
Loading responseExcessive/rapid pronation of subtalar jointCompensatory hypermobility if arch is collapsed; increases fascial elongation
MidstanceReduced midstance time; early heel risePatient hurries through painful phase; weight transferred laterally
Propulsion/push-offReduced hallux dorsiflexion (windlass mechanism inhibited by pain)Failure to engage windlass; arch remains low; continued fascial overload
SwingAntalgic shortened stride length (ipsilateral)Reduces ground contact time on affected side
CadenceReduced overall speed; increased double support timeGeneral antalgic gait
Trunk/pelvisLateral trunk lean away from painful sideReduces ground reaction force on affected foot
Pressure analysis: Increased lateral forefoot pressure (offloading medial heel); reduced heel peak pressure compared to contralateral side; high arch patients show concentrated central heel loading.


2. HALLUX LIMITUS / RIGIDUS

Pathophysiology

Hallux limitus (HL) describes restricted dorsiflexion of the first metatarsophalangeal joint (MTPJ) — functional (<65° dorsiflexion with the foot on the ground is required for normal gait; <20° = significant limitation). Hallux rigidus (HR) is the end-stage where dorsiflexion is completely abolished due to osteophyte formation and joint destruction.
The pathomechanics begin with cartilage degradation at the first MTPJ, progressing through the Regnauld classification:
  • Grade 1 (Limitus): Decreased ROM, mild dorsal osteophytes, minimal joint space loss
  • Grade 2: Moderate osteophytes, 50% joint space loss, pain through arc of motion
  • Grade 3 (Rigidus): Severe osteophytes, <25% joint space, essentially no pain-free motion
  • Grade 4: Global joint destruction
The underlying mechanism involves repetitive impaction of the dorsal articular surface of the proximal phalanx base against the first metatarsal head during push-off dorsiflexion. This causes subchondral sclerosis, joint space narrowing, and progressive dorsal osteophyte formation (the "dorsal bump"). The joint capsule fibroses, further limiting motion.
Contributing factors:
  • Elevated first metatarsal (functional) — increased cartilage impaction during dorsiflexion
  • Pronated foot — forces the hallux into a functionally pronated position, altering MTPJ mechanics
  • Long first metatarsal / Morton's foot
  • Trauma (sesamoid fracture, turf toe)
  • Systemic arthritis (gout, RA, psoriatic arthritis)
Risk factors:
  • Female sex (higher prevalence)
  • Age >30 (peak onset 3rd–5th decade)
  • Family history
  • Prior hallux valgus surgery
  • Occupational loading (kneeling, squatting)
  • Wearing high heels (increased MTPJ dorsiflexion demand)

Assessment

Subjective:
  • Dorsal first MTPJ pain and stiffness; worse during push-off, stairs, wearing heeled shoes
  • Patient may notice a dorsal "bump"; footwear fitting problems
  • Progressive loss of activity tolerance
Objective:
  • First MTPJ ROM (non-weight-bearing): passive and active dorsiflexion (normal ≥65°); note end feel (hard = bone, firm = capsular)
  • Jack's test (windlass): weight-bearing hallux dorsiflexion; pain and restriction confirm HL
  • Functional hallux limitus test: Assess WB vs NWB dorsiflexion difference (pronation-driven HL shown by improvement in NWB)
  • Palpation: dorsal osteophyte, joint line tenderness
  • Subtalar joint ROM (assess for hyperpronation)
  • FPI-6
  • Gait observation (see below)
  • Footwear assessment
Investigations:
  • Weight-bearing X-ray (AP, lateral, oblique — essential): joint space, osteophyte extent, sesamoid position (Grading per Regnauld/Coughlin)
  • MRI: cartilage mapping if surgical planning needed
  • Ultrasound: synovitis, effusion

Management

Conservative (First Line)

  1. Foot orthoses — Morton's extension / carbon fibre stiffened orthosis to reduce MTPJ dorsiflexion demand (see prescription)
  2. Footwear modification — stiff-soled rocker-bottom shoe or carbon fibre shank; wide toe box; avoid heels
  3. Activity modification — reduce activities requiring push-off (running → cycling/swimming)
  4. NSAIDs — short-term analgesia; topical diclofenac
  5. Toe mobilisation exercises — for Grade 1/2; joint mobilisation by podiatrist
  6. Patient education

Second Line

  1. Intra-articular corticosteroid injection — ultrasound-guided; short-term symptom relief; not suitable for Grade 3/4 (joint too restricted)
  2. Intra-articular hyaluronic acid — viscosupplementation; limited evidence
  3. Custom foot orthoses — with functional control addressing pronation
  4. Toe splinting/digital orthosis — for hallux alignment

Last Resort (Surgical)

  • Cheilectomy — dorsal osteophyte excision; indicated Grades 1–2; preserves joint; good outcomes in well-selected patients (Lau et al., 2001 — Miller's)
  • Interpositional arthroplasty — for Grade 2–3; cartilage substitution
  • First MTPJ arthrodesis (fusion) — gold standard for Grade 3–4; eliminates pain; sacrifices motion; 10° dorsiflexion in sagittal plane is optimal position
  • Total joint replacement — limited evidence; high revision rates

Orthotic Prescription — Hallux Limitus/Rigidus

ComponentSelectionRationale
BaseSlimflex (or equivalent) OR EVA 2mmSlimflex for mild–moderate HL (some flexibility retained); stiff EVA for more rigid prescription
'D' Filler (6mm)✓ (bilateral)Supports medial longitudinal arch; reduces hyperpronation that functionally elevates the first ray and worsens MTPJ impaction
Morton's extension✓ under hallux (bilateral)Critical component: extends under the hallux to the tip of the toe as a rigid platform — prevents dorsiflexion at the MTPJ during push-off, dramatically reducing cartilage impaction and pain; made from semi-rigid EVA or carbon fibre plate
RF Valgus wedge 3–4°If hyperpronation confirmed on FPICorrects calcaneal eversion → reduces functional hallux limitus secondary to pronation
Heel Raise (4mm)Consider for Grade 2+Shifts weight-bearing proximally; reduces push-off demand
Top coverPoronCushioning over sensitive dorsal MTPJ area; reduces forefoot loading pressures
Morton's extension rationale: In HL/HR, the primary orthotic goal is to reduce MTPJ dorsiflexion during the propulsive phase. The Morton's extension provides a rigid lever under the hallux: as the foot approaches push-off, rather than bending at the MTPJ, the hallux and extension lift as one unit, distributing load proximally. This decompresses the dorsal joint surface and osteophyte region. (Note: the D' filler simultaneously addresses any hyperpronation-driven first ray elevation.)

Gait Analysis — Hallux Limitus/Rigidus

PhaseDeviationExplanation
Push-off / terminal stanceAbsent or severely reduced hallux dorsiflexion at 1st MTPJCore deviation; patient cannot dorsiflex hallux ≥65°; propulsive force reduced
PropulsionTransfer metatarsalgia gait — weight transferred laterally to lesser metatarsalsAvoids loading the immobile first ray; patient "rolls off" lateral forefoot
Pronation compensationExcessive midfoot pronation ("too many toes" sign on posterior view)Attempts to bring medial forefoot to ground by supinating forefoot/everting rearfoot
Abductory twistAbrupt medial swing of heel just before heel liftHallux cannot dorsiflex → subtalar compensates with external rotation torque
Stride lengthShortened step length (particularly propulsive phase)Cannot load through hallux → reduced push-off power
Hip and kneeIncreased hip external rotationAllows forefoot to supinate; reduces MTPJ demand
TrunkContralateral trunk lean during push-offReduces ipsilateral ground reaction force
Key observation tool: Footprint analysis — medial first metatarsal head region will show reduced pressure; central/lateral forefoot pressure increased.


3. MORTON'S NEUROMA

Pathophysiology

Morton's neuroma is not a true neuroma (no axonal sprouting) but rather a compressive perineural fibrosis of the common plantar digital nerve — most frequently the 3rd interspace (between 3rd and 4th metatarsal heads), followed by the 2nd interspace. The 1st and 4th are rarely affected.
The pathological process involves:
  1. Repetitive compression of the digital nerve between the metatarsal heads, particularly under the deep transverse metatarsal ligament (DTML) — which sits dorsal to the nerve
  2. During the propulsive phase of gait, as the MTP joints dorsiflex, the DTML is pulled taut, compressing the nerve from above whilst the ground compresses from below
  3. This produces endoneural oedema → perineural fibrosis → demyelination of the nerve
  4. The 3rd interspace is most vulnerable due to the anastomosis between medial and lateral plantar nerves creating a slightly larger nerve at this level, and the greater mobility of the 3rd/4th metatarsals (Gray's Anatomy for Students)
Risk factors:
  • Female sex (predilection ~10:1 — related to high heel / narrow toe box footwear)
  • High-heeled or narrow toe-box shoes (force plantar flexion of MTP joints → increased DTML tension)
  • Splaying foot / hypermobile metatarsals
  • Age 40–60 years
  • High-impact sports (running, ballet)
  • Bunions causing 2nd space compression

Assessment

Subjective:
  • Burning, shooting, or electric-shock pain in the forefoot, typically 3rd interspace
  • Radiation into adjacent toes (>60% of patients) — often 3rd and 4th toes
  • Numbness/paraesthesia in affected toes (~40%)
  • Worsened by narrow/pointed shoes, heels, prolonged standing
  • Relief on removing shoes and rubbing the forefoot
  • May describe a sensation of walking on a pebble or crumpled sock
Objective:
  • Palpation: Direct tenderness in the plantar interspace — just distal to metatarsal heads
  • Mulder's click/sign: Compress forefoot medially and laterally (metatarsal squeeze) whilst palpating the interspace from plantar aspect — a palpable "click" with reproduction of symptoms = positive Mulder's (high clinical value)
  • Thumb-index squeeze test: Digital pressure in the interspace
  • Assess footwear: toe box width, heel height
  • FPI-6, metatarsal alignment
Investigations:
  • Weight-bearing X-ray: Exclude bony pathology (stress fracture, metatarsal lesion); neuroma is not visible on X-ray
  • Ultrasound: First line — can visualise the hypoechoic ovoid mass in the interspace (>5mm is typically symptomatic); also guides injection
  • MRI: High sensitivity; demonstrates low T1, high T2 signal mass in interspace; useful when US equivocal or surgical planning
Differential: MTP synovitis/instability (positive drawer test), stress fracture (XR/MRI), bursitis, metatarsalgia, Freiberg's infarction

Management

Conservative (First Line)

  1. Footwear modification — MOST IMPORTANT first-line intervention (Miller's): wider toe box, low heels (<2.5cm), cushioned sole; reduces DTML compression
  2. Metatarsal dome/pad — placed proximal to the metatarsal heads to splay and depress the metatarsals, widening the interspace and decompressing the nerve
  3. Activity modification — avoid prolonged high-impact loading; sports shoe advice
  4. NSAIDs — topical or oral for analgesia

Second Line

  1. Corticosteroid injection — ultrasound-guided; ~50% positive response; short-term relief (Miller's); risk of plantar fat pad atrophy and hammertoe deformity if repeated
  2. Local anaesthetic block — diagnostic and therapeutic
  3. Alcohol sclerosing injections — NOT recommended; not proved effective (Miller's)
  4. Custom foot orthoses — metatarsal dome component; forefoot padding; correction of any contributing hyperpronation

Last Resort (Surgical)

  • Neurectomy (excision of neuroma) — either dorsal or plantar approach; dorsal avoids scar on weight-bearing surface; plantar gives better exposure
  • Excision of DTML ± neuroma
  • Risk: Stump neuroma formation (~30–40% of cases cause ongoing symptoms); if recurrent neuroma, revision excision with deeper resection required

Orthotic Prescription — Morton's Neuroma

ComponentSelectionRationale
BaseEVA 2mm or Poron 3mm (bilateral)Poron preferred for shock absorption in forefoot; reduces metatarsal head impact
'D' Filler (6mm)✓ (bilateral)Supports arch; reduces forefoot splay associated with hyperpronation; reduces load transfer to interspace
Met Dome✓ — positioned proximal to 3rd interspace (bilateral)Primary orthotic intervention: the metatarsal dome placed just proximal to the 3rd/4th metatarsal heads depresses and separates the metatarsals, directly widening the interspace and reducing DTML compression on the nerve
Reverse Morton'sConsider if there is forefoot valgusOffloads the lateral forefoot
Top coverPoronCompliant, pressure-distributing surface; reduces plantar forefoot peak pressures
Met Dome rationale: The dome's position proximal to the metatarsal heads acts as a lever: during weight-bearing it pushes the metatarsal necks dorsally, spreading the metatarsal heads apart. This increases the intermetatarsal space, reducing the compressive force on the interdigital nerve. Studies support metatarsal pads as the most effective conservative orthotic intervention for Morton's neuroma. The D' filler is secondary but addresses any arch-related forefoot overloading.

Gait Analysis — Morton's Neuroma

PhaseDeviationExplanation
Forefoot loading / midstanceRapid transfer through forefoot; reduced forefoot contact timePain avoidance; patient hurries through metatarsal head loading
Push-offReduced 3rd/4th MTP dorsiflexion; supinated push-off (lateral roll)Reduces DTML tension over neuroma; patient offloads the affected interspace
Step widthIncreased (wider base of support)Reduces intermetatarsal compression
Footwear compensatoryToe-out gait (external foot progression)Reduces pressure in 3rd space by changing load distribution
Cadence/speedReduced on painful sideAntalgic
TrunkLateral lean away from affected forefootReduces ipsilateral forefoot loading
Shoe wear patternIncreased lateral forefoot wearReflects offloading of 3rd interspace


4. ACHILLES TENDINOPATHY

Pathophysiology

Achilles tendinopathy is a failed tendon healing response — a degenerative condition (tendinosis) rather than inflammatory. Two distinct presentations with different mechanisms:

Non-insertional (mid-portion, 2–6cm above calcaneal insertion)

The "watershed zone" — an area of relative avascularity 2–6cm proximal to the calcaneal insertion. Repetitive compressive and tensile loading causes:
  1. Tenocyte activation → upregulation of matrix metalloproteinases (MMPs)
  2. Collagen type I → type III substitution (weaker, less organised)
  3. Intratendinous neovascularisation (Doppler-visible vessels) with associated sensory nerve ingrowth — source of pain
  4. Mucoid degeneration, calcification, and eventual partial/complete rupture

Insertional tendinopathy

Occurs at the bony insertion on the posterior calcaneal tuberosity. The mechanism includes:
  • Compressive loading between the tendon and the posterosuperior calcaneus (especially in equinus/high-arch foot)
  • Haglund's deformity (posterosuperior calcaneal prominence) — mechanically impinges the tendon
  • Results in reactive/degenerative enthesopathy with calcification within the tendon substance at insertion
  • A retrocalcaneal bursa may also be involved
Cook and Purdam's Continuum Model (2009): Reactive tendinopathy → Tendon dysrepair → Degenerative tendinopathy — key concept in understanding progression and treatment rationale.
Risk factors:
  • Overtraining / sudden increase in running volume
  • Male sex (higher incidence in running sports)
  • Age 35–45 years (peak)
  • Hyperpronation (increases Achilles torsional stress)
  • Equinus / gastrocnemius tightness (increases tensile load)
  • Haglund's deformity (insertional)
  • Fluoroquinolone antibiotic use (ciprofloxacin — increases tendon rupture risk)
  • Corticosteroid injections near the tendon
  • Systemic conditions: RA, gout, spondyloarthropathy, diabetes, hypercholesterolaemia

Assessment

Subjective:
  • Mid-portion: Pain and stiffness 2–6cm above calcaneus; worse morning/after rest (post-static dyskinesia); worse with running/sport
  • Insertional: Pain directly at back of heel; worse with shoe counter pressure
  • Activity-related pain that warms up then worsens post-activity
  • VISA-A questionnaire (validated outcome measure for Achilles tendinopathy; max 100 = asymptomatic)
Objective:
  • Palpation: Mid-portion — fusiform thickening, "Royal London Hospital Test" (palpate thickening, passively dorsiflex ankle — if pain reduces when moved from neutral to plantarflexion = mid-portion tendinopathy); insertional — pain at bone-tendon junction
  • Arc sign: If a thickened area moves with tendon during dorsiflexion/plantarflexion = intratendinous pathology (vs paratenon pathology which doesn't move)
  • Silfverskiöld test — assess gastrocnemius vs soleus tightness
  • Calf raise test: Single leg heel raise endurance (<25 repetitions may indicate weakness)
  • Thompson (Simmonds) test — exclude complete rupture
  • Rearfoot alignment (FPI-6); hyperpronation assessment
Investigations:
  • Ultrasound: First line — shows tendon hypoechogenicity, thickness, intratendinous tears, calcification, neovascularisation (Doppler); insertional calcification
  • MRI: Intratendinous signal change, partial tear, Haglund's, bursitis
  • X-ray: Calcaneal Haglund's deformity, calcific deposits at insertion

Management

Conservative (First Line)

  1. Eccentric loading exercises — Alfredson protocol (heel drops on a step, knee straight AND bent, 3×15 reps BID, 12 weeks); gold standard for mid-portion tendinopathy; heavy slow resistance (HSR) is an evidence-based alternative
  2. Heel raises — immediate symptom relief by reducing Achilles tendon excursion; essential for insertional (caution: may worsen insertional if they increase compressive load against calcaneum)
  3. Activity modification — load management; avoid impact sports acutely; graded return to running plan
  4. Footwear — soft heel counter (especially insertional); avoid flat/barefoot shoes; running shoe with heel drop ≥8mm for mid-portion
  5. NSAIDs / analgesia — GTN patches (topical glyceryl trinitrate — evidence for mid-portion); topical NSAIDs
  6. Physiotherapy / stretching — calf flexibility; eccentric programme supervision

Second Line

  1. ESWT — good evidence for mid-portion; 3–6 sessions; also NICE-supported
  2. PRP injection — ultrasound-guided; emerging evidence; may be more beneficial than corticosteroid for tendons
  3. Corticosteroid injection — limited to peritendinous injection only (NOT into tendon substance — rupture risk); short-term relief for paratendinopathy; NEVER inject into the tendon directly (Miller's)
  4. High-volume injection — saline/steroid/local anaesthetic; disrupts neovascular ingrowth; mid-portion
  5. Orthotics — custom orthoses with heel raise and rearfoot control (see prescription)

Last Resort (Surgical)

  • Mid-portion: Longitudinal tendon debridement (intratendinous); Stripping of paratenon; Neovessel ablation
  • Insertional: Calcaneal osteotomy (Zadek/dorsal wedge) to decompress insertion; excision of Haglund's deformity; detachment and reattachment of tendon with calcification excision
  • Complete rupture: Surgical repair vs conservative (both accepted; UKSTAR trial: functional bracing non-inferior to surgery in uncomplicated cases)

Orthotic Prescription — Achilles Tendinopathy

ComponentSelectionRationale
BaseEVA 2mm (bilateral)Firm base for rearfoot control; holds wedge and heel raise components
'D' Filler (6mm)✓ (bilateral)Supports medial longitudinal arch; controls hyperpronation which increases torsional load on Achilles tendon
Heel Raise (4mm standard or 6–8mm if specified)✓ (bilateral)Core component: reduces the degree of ankle dorsiflexion required during gait, thereby reducing Achilles tendon excursion and tensile load; bilaterally prescribed to prevent pelvic tilt; particularly important in equinus
Cobra Pad / heel cup✓ for insertional typeSurrounds and cups the posterior calcaneus; limits compressive impingement between posterosuperior calcaneus and tendon insertion; especially effective in Haglund's
RF Varus 3–4°If hyperpronation confirmedControls subtalar eversion which externally rotates tibia and increases Achilles torsional stress
Top coverPoronHeel cushioning; reduces calcaneal impact loading
Heel raise rationale: The Achilles tendon is under maximum tensile load at maximum dorsiflexion. By raising the heel 4–8mm, the orthosis reduces the angular demand at the ankle during midstance and propulsion, reducing peak Achilles tendon stress. For insertional tendinopathy, the heel raise also moves the posterior calcaneal contact point anteriorly, reducing direct shoe counter compression against the insertion. A bilateral heel raise prevents a leg length discrepancy effect.

Gait Analysis — Achilles Tendinopathy

PhaseDeviationExplanation
Initial contactMore forefoot-first contact; reduced heel strikeAvoids rapid Achilles loading that occurs during heel-to-toe transition
MidstanceReduced ankle dorsiflexion excursionPatient limits Achilles elongation through equinus compensation
Propulsion / push-offReduced plantarflexion power; shortened push-offAchilles acts as primary push-off driver; pain inhibits full plantarflexion force
Early swingReduced ankle dorsiflexion in swing (steppage gait pattern in severe cases)Compensatory
Hip/kneeIncreased knee flexion; reduced hip extensionCompensates for reduced plantarflexion; alters sagittal plane mechanics
Stride lengthReduced ipsilateral stride lengthAntalgic; reduced push-off
PronationExcessive/prolonged pronation in midstanceOften contributing factor; increases torsional Achilles stress
CadenceIncreased cadence with shorter stepsReduces time under load per step


5. POSTERIOR TIBIAL TENDON DYSFUNCTION (PTTD) / ADULT ACQUIRED FLATFOOT DEFORMITY (AAFD)

Pathophysiology

The posterior tibial tendon (PTT) is the primary dynamic stabiliser of the medial longitudinal arch and the main invertor of the subtalar joint. It originates from the posterior tibia and inserts broadly onto the navicular tuberosity, plantar cuneiforms, cuboid, and metatarsal bases.
PTTD involves a spectrum from tendon degeneration → insufficiency → arch collapse → rigid deformity:
Tendon pathology: Degenerative changes (mucoid degeneration, collagen disorganisation) — similar to other tendinopathies — typically occurring in the "zone of relative hypovascularity" posterior to the medial malleolus. Once the tendon loses its ability to invert the hindfoot during the "heel rise" phase of gait, the spring (calcaneonavicular) ligament — the primary static stabiliser of the talonavicular (TN) joint — comes under increasing stress. The superomedial band (70% of spring ligament complex) fails progressively (Miller's).
Deformity progression (Johnson & Strom / Myerson Staging):
  • Stage 1: Tendon tenosynovitis, no deformity; patient can perform single-limb heel rise (SLHR)
  • Stage 2: Tendon elongated/partially torn; flexible flatfoot deformity; cannot SLHR; hindfoot valgus, forefoot abduction ("too many toes" sign), medial arch collapse
  • Stage 3: Rigid flatfoot deformity; subtalar arthritis; cannot SLHR; lateral impingement (subfibular impingement — calcaneus abuts fibula)
  • Stage 4: Ankle joint involved; valgus talar tilt in mortise
The "too many toes" sign (>2 toes visible lateral to fibula on posterior observation) indicates forefoot abduction, pathognomonic of Stage 2+.
The spring ligament — the calcaneonavicular ligament — is the primary static stabiliser of the TN joint. Loss of dynamic PTT support rapidly accelerates spring ligament failure (Miller's).
Risk factors:
  • Female sex (majority of cases)
  • Obesity / BMI >30
  • Age 40–60 years
  • Pre-existing pes planus
  • Hypertension (associated in epidemiological studies — possibly microvascular)
  • Seronegative spondyloarthropathies (psoriatic arthritis, Reiter's syndrome — Miller's)
  • Diabetes
  • Corticosteroid injection (to PTT or medial ankle)
  • Inflammatory arthritis (RA)

Assessment

Subjective:
  • Medial ankle/foot pain (Stage 1–2); may develop lateral ankle/subfibular pain (Stage 3)
  • Progressive arch flattening noticed by patient
  • Difficulty with footwear; difficulty walking on uneven surfaces
  • Fatigue and aching in the medial foot
Objective:
  • "Too many toes" sign — posterior observation WB
  • Single-limb heel rise (SLHR) test — inability or pain = Stage 2+; normal = heel should invert as it rises (requires functioning PTT)
  • Hindfoot alignment — WB calcaneal eversion; FPI-6; note if flexible (stages 1–2) or rigid (stage 3)
  • Forefoot abduction — "too many toes," talonavicular coverage angle on XR
  • Subtalar ROM — reduced inversion indicates approaching Stage 3 rigidity
  • Navicular drop test (Brody) — measures arch flexibility
  • Palpation — PTT posterior to medial malleolus; spring ligament (anteromedial to sustentaculum tali); tibionavicular ligament
  • Silfverskiöld — gastrocnemius tightness frequently co-exists
Investigations:
  • Weight-bearing X-ray (AP, lateral, oblique): Talonavicular coverage, calcaneal pitch, Meary's angle (talo–first metatarsal angle — normally <4°), medial cuneiform height
  • MRI: Definitive assessment of PTT integrity (Grade I = thickening, Grade II = partial tear, Grade III = complete rupture); spring ligament; deltoid ligament
  • Ultrasound: PTT — tenosynovitis, tears; dynamic assessment

Management

Conservative (First Line)

  1. Foot orthoses — Stage 1–2; medial arch support + rearfoot posting (see prescription); University of California Biomechanics Laboratory (UCBL) device for severe Stage 2
  2. Ankle-Foot Orthosis (AFO) — for Stage 2B/early Stage 3: Arizona AFO or hinged AFO; provides rigid medial arch and rearfoot control
  3. Activity modification — reduce high-impact activity; avoid hills and uneven terrain
  4. Physiotherapy — PTT eccentric strengthening; tibialis posterior progressions; balance/proprioception training
  5. NSAIDs / analgesia
  6. CAM boot / immobilisation — Stage 1 acute tenosynovitis (4–6 weeks)
  7. Patient education and weight management

Second Line

  1. Corticosteroid injection — peritendinous injection (NOT into tendon — rupture risk); for Stage 1 tenosynovitis under ultrasound guidance
  2. ESWT — limited but emerging evidence for tendinopathic change
  3. Bracing escalation — from foot orthosis to UCBL to AFO
  4. Custom orthoses — more detailed prescription with medial flange, UCBL shell, rearfoot control

Last Resort (Surgical) — Staged per Deformity

  • Stage 1: PTT tenosynovectomy (debridement of inflamed tendon sheath)
  • Stage 2: Combination procedures — Flexor digitorum longus (FDL) tendon transfer (to navicular) + medialising calcaneal osteotomy (Koutsogiannis) ± lateral column lengthening (Evans calcaneal osteotomy for forefoot abduction) ± Cotton osteotomy (plantar-flexion first ray) (Miller's)
  • Stage 3: Double (subtalar + TN) or triple arthrodesis (subtalar + TN + CC joints)
  • Stage 4: As Stage 3 ± medialising calcaneal osteotomy ± deltoid reconstruction ± ankle replacement/arthrodesis

Orthotic Prescription — PTTD / AAFD

ComponentSelectionRationale
BaseEVA 2mm (bilateral, or unilateral if asymmetric)Semi-rigid base holds rearfoot posting and arch components in correct position
'D' Filler (6mm)✓ (bilateral / affected side)Primary arch fill: supports the collapsed medial longitudinal arch, reducing medial midfoot strain; prevents further navicular drop; offloads the spring ligament by providing a physical arch support; fills the large arch void created by the flatfoot deformity — in significant flatfoot the D' filler may need to be increased beyond standard 6mm
Cobra Pad✓ (affected side)Medial arch and heel cup; conforms to and supports the medial longitudinal arch proximally
RF Valgus correction → RF Varus 4–5°✓ (bilateral)Corrects calcaneal eversion (hindfoot valgus) — inverts the calcaneus, reduces subtalar pronation, and supports the PTT by reducing the eversion load it must counteract
Heel Raise (4mm)Consider (bilateral)Accommodates gastrocnemius tightness (commonly co-exists); reduces Achilles tensile load
FF Varus 3°If forefoot valgus presentCorrects flexible forefoot valgus deformity
Top coverPoron or NeopreneCushioning; neoprene for warmer, snugger fit if AFO-type is needed
Important escalation: For Stage 2B/Stage 3, a simple insole is insufficient. Refer for UCBL custom shell or rigid AFO.
D' Filler rationale for PTTD: In adult acquired flatfoot, the medial longitudinal arch is collapsed. The D' filler (6mm EVA) literally fills the gap between the insole base and the plantar surface of the collapsed arch. Without this fill, the medial arch component of the orthosis would have no ground contact and provide no support. In PTTD, this is the most important single component: it directly props the navicular and medial midfoot, offloads the failing spring ligament, and reduces the moment arm demanding inversion from the already compromised PTT. In severe flatfoot, the filler may be increased to 8–10mm or built-up medial flange prescribed.

Gait Analysis — PTTD / AAFD

PhaseDeviationExplanation
"Too many toes" signWB posterior view: >2 toes visible lateral to fibulaForefoot abduction; talonavicular joint breakdown; pathognomonic
Initial contactFlat-footed (reduced heel inversion at IC)Loss of supination at heel strike due to PTT failure
Loading responseRapid, excessive, prolonged pronation; arch collapse visiblePTT cannot decelerate subtalar eversion; arch drops quickly
MidstanceSustained arch collapse; calcaneal valgus; medial bulge at navicularDynamic arch support absent; midfoot overloads medially
Heel rise / terminal stanceAbsent or impaired heel inversion on heel rise (diagnostic); delayed or absent heel offCore gait finding — PTT normally inverts calcaneus at heel rise; its failure is directly visible here
Push-offReduced propulsion through medial column; weight transferred laterallyUnstable medial column unable to transmit push-off forces efficiently
SwingSlightly shortened swing (antalgic)
Trunk/pelvisMedial trunk lean over affected sideCompensates for poor medial column stability
CadenceReduced speed; wider baseInstability compensation
Key diagnostic gait test: Ask patient to perform a single-leg heel rise on the affected side — inability, pain, or failure of heel to invert confirms PTT insufficiency (Stage 2+).


QUICK REFERENCE: WLV PRESCRIPTION FORM — COMPONENT RATIONALE MATRIX

ComponentPFHL/HRMorton'sAchillesPTTD
Base: EVA 2mm
'D' Filler 6mm✓ (reduce fascial strain)✓ (reduce pronation/first ray elevation)✓ (reduce forefoot splay)✓ (arch/pronation control)✓✓ (fills arch void; core component)
Cobra Pad✓ (medial heel cup)✓ (insertional)✓ (medial arch)
Heel Raise 4mm✓ (equinus)Consider✓✓ (reduce Achilles load)Consider
Met Dome✓✓ (metatarsal splay)
Morton's Extension✓✓ (reduce MTPJ dorsiflexion)
RF Varus 3–5°If pronatedIf pronatedIf pronated✓✓ (correct hindfoot valgus)
Top Cover: Poron

THE D' FILLER — EXPLAINED (Your Original Question)

From your WLV Simple Insole Prescription Form: 'D' Filler (6mm standard) is a pre-cut block of firm EVA foam (or equivalent material) with a D-shaped cross-sectional profile that is bonded to the plantar surface of the orthotic base beneath the medial longitudinal arch. The flat face of the D contacts the base; the curved face contacts the plantar arch.
Function: It physically fills the concave space under the arch of the insole (created because the base conforms to the foot's arch shape), ensuring:
  1. The insole lies flat in the shoe
  2. Upward arch support force is transferred to the plantar foot
  3. The medial arch is physically supported during the stance phase of gait
  4. It is the primary mechanical means by which the insole controls arch height and reduces pronation
The "6mm standard" refers to the height of the D-shaped EVA block at its apex — this can be modified up (8–10mm for significant flatfoot/PTTD) or down (4mm for a sensitive arch or mild deformity).

*Sources: Miller's Review of Orthopaedics 9th Edition; Gray's Anatomy for Students; Imaging Anatomy Vol 3 (Bones, Joints); Rockwood & Green's Fractures in Adults 10th Ed 2025; WLV Simple Insole Prescription Form (WP004)*You've run out of free credits. Sign up for a free account to continue using Orris.
This is a shared conversation. Sign in to Orris to start your own chat.